These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 19873694)

  • 1. Tinea capitis: diagnostic criteria and treatment options.
    Meadows-Oliver M
    Dermatol Nurs; 2009; 21(5):281-6. PubMed ID: 19873694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tinea capitis: diagnostic criteria and treatment options.
    Meadows-Oliver M
    Pediatr Nurs; 2009; 35(1):53-7. PubMed ID: 19378575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment and management of tinea capitis in children.
    Ali S; Graham TA; Forgie SE
    Pediatr Emerg Care; 2007 Sep; 23(9):662-5; quiz 666-8. PubMed ID: 17876261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric tinea capitis: recognition and management.
    Möhrenschlager M; Seidl HP; Ring J; Abeck D
    Am J Clin Dermatol; 2005; 6(4):203-13. PubMed ID: 16060708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
    Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D
    Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial fungal infections.
    Kelly BP
    Pediatr Rev; 2012 Apr; 33(4):e22-37. PubMed ID: 22474120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options in the treatment of tinea capitis.
    Chan YC; Friedlander SF
    Expert Opin Pharmacother; 2004 Feb; 5(2):219-27. PubMed ID: 14996619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tinea capitis in children: a systematic review of management.
    Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinea Capitis: An Updated Review.
    Leung AKC; Hon KL; Leong KF; Barankin B; Lam JM
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):58-68. PubMed ID: 31906842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tinea capitis update: a continuing conflict with an old adversary.
    Chen BK; Friedlander SF
    Curr Opin Pediatr; 2001 Aug; 13(4):331-5. PubMed ID: 11717558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral griseofulvin remains the treatment of choice for tinea capitis in children.
    Bennett ML; Fleischer AB; Loveless JW; Feldman SR
    Pediatr Dermatol; 2000; 17(4):304-9. PubMed ID: 10990583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tinea capitis: a treatment update.
    Roberts BJ; Friedlander SF
    Pediatr Ann; 2005 Mar; 34(3):191-200. PubMed ID: 15792111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
    Fleece D; Gaughan JP; Aronoff SC
    Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinea capitis.
    Alvarez MS; Silverberg NB
    Cutis; 2006 Sep; 78(3):189-96. PubMed ID: 17036663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose oral terbinafine in the treatment of pediatric tinea capitis under 2 years old.
    Zhou YB; Chao JJ; Xiao YY; Ma L
    Dermatol Ther; 2022 Apr; 35(4):e15320. PubMed ID: 35038221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of terbinafine in children.
    Gupta AK; Cooper EA; Lynde CW
    Dermatol Clin; 2003 Jul; 21(3):511-20. PubMed ID: 12956204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.